Yuyu Pharma Inc Cash Flow Conversion Efficiency
Yuyu Pharma Inc cash flow conversion efficiency. Based on the latest financial reports, Yuyu Pharma Inc (000227) has a cash flow conversion efficiency ratio of 0.006x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩836.62 Million ≈ $566.97K USD) by net assets (₩139.10 Billion ≈ $94.26 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Yuyu Pharma Inc (2014–2024)
Cash flow conversion efficiency of Yuyu Pharma Inc from 2014 to 2024. This chart illustrates how Yuyu Pharma Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Yuyu Pharma Inc share price for real-time trading data and today's change.
Yuyu Pharma Inc Cash Flow Conversion Ratio Explained
Yuyu Pharma Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Yuyu Pharma Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Yuyu Pharma Inc ranked by their cash flow conversion efficiency. Also see Yuyu Pharma Inc market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Harrisons Malayalam Limited
NSE:HARRMALAYA
|
0.033x |
|
TREJHARA SOLUTIONS LIMITED
NSE:TREJHARA
|
0.008x |
|
Kinetiko Energy Ltd
AU:KKO
|
-0.033x |
|
Desert Gold Ventures Inc
V:DAU
|
-1.378x |
|
Shanghai Kai Kai Industry Co Ltd B
SHG:900943
|
0.006x |
|
Payment Financial Technologies Ltd
TA:PMNT
|
0.344x |
|
Better World Green Public Company Limited
BK:BWG
|
0.032x |
|
InBioGen Co Ltd
KO:101140
|
-0.010x |
Annual Cash Flow Conversion Efficiency for Yuyu Pharma Inc (2014–2024)
The table below shows the annual cash flow conversion efficiency of Yuyu Pharma Inc from 2014 to 2024. Review Yuyu Pharma Inc free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩135.06 Billion ≈ $91.53 Million |
₩24.95 Billion ≈ $16.91 Million |
0.185x | +5182.83% |
| 2023-12-31 | ₩120.36 Billion ≈ $81.56 Million |
₩420.86 Million ≈ $285.21K |
0.003x | +106.93% |
| 2022-12-31 | ₩123.37 Billion ≈ $83.61 Million |
₩-6.23 Billion ≈ $-4.22 Million |
-0.050x | -244.10% |
| 2021-12-31 | ₩128.69 Billion ≈ $87.21 Million |
₩4.51 Billion ≈ $3.06 Million |
0.035x | +253.64% |
| 2020-12-31 | ₩117.04 Billion ≈ $79.31 Million |
₩-2.67 Billion ≈ $-1.81 Million |
-0.023x | -115.66% |
| 2019-12-31 | ₩90.54 Billion ≈ $61.36 Million |
₩13.19 Billion ≈ $8.94 Million |
0.146x | +107.05% |
| 2018-12-31 | ₩86.87 Billion ≈ $58.87 Million |
₩6.11 Billion ≈ $4.14 Million |
0.070x | +937.85% |
| 2017-12-31 | ₩82.83 Billion ≈ $56.14 Million |
₩561.35 Million ≈ $380.42K |
0.007x | -94.60% |
| 2016-12-31 | ₩78.29 Billion ≈ $53.06 Million |
₩9.82 Billion ≈ $6.65 Million |
0.125x | +179.12% |
| 2015-12-31 | ₩73.73 Billion ≈ $49.97 Million |
₩-11.68 Billion ≈ $-7.92 Million |
-0.158x | -930.90% |
| 2014-12-31 | ₩71.49 Billion ≈ $48.45 Million |
₩1.36 Billion ≈ $923.95K |
0.019x | -- |
About Yuyu Pharma Inc
Yuyu Pharma, Inc. develops and markets pharmaceutical products in Korea and United States. The company offers various prescription drugs, non-prescription drugs, quasi-drugs, health functional foods, and other products in the fields of neurology, endocrinology, otolaryngology, etc. The company was formerly known as YuYu Inc. and changed its name to Yuyu Pharma, Inc. in May 2008. Yuyu Pharma, Inc.… Read more